Cabot Corporation (CBT) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2025 (Second Quarter of Fiscal 2025). Cabot Corporation operates two reportable segments: Reinforcement Materials (reinforcing carbons and engineered elastomer composites) and Performance Chemicals (specialty carbons, battery materials, fumed metal oxides, and others). The company is a large accelerated filer incorporated in Delaware.
Key Financial Metrics
| Metric (in millions) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Net Sales | $936 | $1,019 | $1,891 | $1,977 |
| Gross Profit | $241 | $246 | $476 | $464 |
| Operating Income | $162 | $156 | $317 | $292 |
| Net Income (Cabot Corp) | $94 | $84 | $187 | $134 |
| Diluted EPS | $1.69 | $1.49 | $3.36 | $2.37 |
| Cash from Operations (YTD) | $197 | $281 | $197 | $281 |
| Cash & Equivalents (End Period) | $213 | $206 | $213 | $206 |
| Total Debt (Short + Long Term) | $1,289 | $1,132 | $1,289 | $1,132 |
Note: Debt figures derived from Balance Sheet (Short-term borrowings + Current portion of LT debt + Long-term debt). Q2 2024 debt figures are estimated based on available data points or not explicitly stated for the exact quarter end in the text provided, but YTD cash flow and balance sheet trends are clear.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 8% in Q2 and 4% YTD compared to the prior year. This was driven by lower volumes in Reinforcement Materials (due to lower tire demand) and unfavorable pricing/product mix in both segments (linked to lower raw material costs passed through to customers).
- Profitability Improvement: Despite lower sales, Net Income attributable to Cabot increased 12% in Q2 and 40% YTD. This was primarily due to a significant reduction in "Certain Items" (specifically Argentina currency devaluation losses which were $41M in YTD 2024 vs. $0 in YTD 2025) and higher EBIT in the Performance Chemicals segment.
- Segment Performance:
- Reinforcement Materials: Sales and EBIT declined due to lower tire demand and contract outcomes in South America.
- Performance Chemicals: Sales were flat in Q2 but EBIT increased 61% due to higher volumes (Fumed Metal Oxides) and improved gross profit per ton from price increases and cost optimization.
- Working Capital: Cash from operations decreased YTD by $84 million, largely due to an increase in net working capital (higher receivables and lower payables) compared to the prior year.
Guidance, Outlook, and Risks
- Outlook: Management expects Reinforcement Materials EBIT to decline modestly in Q3 due to uncertain macroeconomic conditions. Performance Chemicals EBIT is expected to be flat sequentially in Q3 as seasonal volume increases are offset by customer destocking in China.
- Tax Rate: The projected Operating Tax Rate for Fiscal 2025 is 27% to 29%.
- Capital Spending: Expected to be between $250 million and $275 million for Fiscal 2025.
- Tariffs: The company is assessing the impact of global tariffs. While most products are manufactured where sold, cross-border sales may face price increases. Customer caution regarding inventory levels due to tariff uncertainty is noted.
- Contingencies: A reserve of $34 million exists for respirator liabilities (asbestos/silicosis claims). Management notes it is reasonably possible that liabilities could change materially in the near term.
Investor Verification Checklist
- Argentina Exposure: Verify the stability of the Argentine subsidiary's operations and the absence of future currency devaluation risks compared to the $41M loss in the prior year.
- Tire Demand Cycle: Monitor global tire production data to validate the "lower volumes" narrative in the Reinforcement Materials segment.
- Working Capital Trends: Review the increase in Accounts Receivable and decrease in Accounts Payable to ensure collection cycles are not deteriorating.
- Respirator Liability Reserve: Assess the adequacy of the $34 million reserve given the "reasonably possible" material change warning in the contingencies note.
- Share Repurchases: Confirm the pace of buybacks ($89M YTD) against the remaining authorization ($10.5M shares remaining).